• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机断层扫描(CT)成像下肿瘤轮廓的形状和肿瘤异质性的纹理是 T1b-T2 期肾细胞癌独立的预后指标。

Computer tomography-based shape of tumor contour and texture of tumor heterogeneity are independent prognostic indicators for clinical T1b-T2 renal cell carcinoma.

机构信息

Department of Urology, Seoul National University Bundang Hospital, 166, Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea.

Department of Radiology, Seoul National University Bundang Hospital, Seongnam-si, South Korea.

出版信息

World J Urol. 2023 Oct;41(10):2723-2734. doi: 10.1007/s00345-023-04543-4. Epub 2023 Aug 2.

DOI:10.1007/s00345-023-04543-4
PMID:37530807
Abstract

PURPOSE

To evaluate association between computer tomography (CT)-based features of renal cell carcinoma (RCC) and survival outcomes.

METHODS

Data of 958 patients with clinical T1b-T2 RCC who underwent partial/radical nephrectomy from June 2003 to March 2022 were retrospectively evaluated. CT images of patients were reviewed by two radiologists for texture analysis of tumor heterogeneity and shape analysis of tumor contour. Patients were divided into three groups according to patterns of CT-based features: (1) favorable feature group (n = 117); (2) intermediate feature group (n = 606); and (3) unfavorable feature group (n = 235). Kaplan-Meier survival analysis and multivariate Cox regression analysis were performed to evaluate overall survival (OS), cancer-specific survival (CSS), and recurrence-free survival (RFS).

RESULTS

RCCs with unfavorable CT-based feature showed larger size on CT, higher nuclear grade, higher rate of histologic necrosis, and higher rate of capsular invasion than those in the other two groups (all p < 0.001). Unfavorable feature was associated with poorer OS (p = 0.001), CSS (p < 0.001), and RFS (p < 0.001) on Kaplan-Meier analysis. In multivariate analysis, intermediate and unfavorable features were independent predictors for recurrence (hazard ratio [HR] 2.51, 95% confidence interval [CI] 1.09-5.79, p = 0.031 and HR 3.71, 95% CI 1.58-8.73, p = 0.003, respectively), but not for overall death or RCC-specific death.

CONCLUSIONS

A combination of irregular tumor contour feature with heterogeneous tumor texture feature on CT is associated with poor RFS in clinical T1b-T2 RCC preoperatively.

摘要

目的

评估基于计算机断层扫描(CT)的肾细胞癌(RCC)特征与生存结果之间的关联。

方法

回顾性分析 2003 年 6 月至 2022 年 3 月期间接受部分/根治性肾切除术的 958 例临床 T1b-T2 RCC 患者的数据。由两名放射科医生对患者的 CT 图像进行复查,以进行肿瘤异质性的纹理分析和肿瘤轮廓的形状分析。根据 CT 特征的模式,将患者分为三组:(1)有利特征组(n=117);(2)中间特征组(n=606);和(3)不利特征组(n=235)。进行 Kaplan-Meier 生存分析和多变量 Cox 回归分析,以评估总生存期(OS)、癌症特异性生存期(CSS)和无复发生存期(RFS)。

结果

与其他两组相比,基于 CT 的不利特征的 RCC 在 CT 上显示出更大的大小、更高的核级、更高的组织学坏死率和更高的包膜侵犯率(均 p<0.001)。基于 Kaplan-Meier 分析,不利特征与较差的 OS(p=0.001)、CSS(p<0.001)和 RFS(p<0.001)相关。在多变量分析中,中间和不利特征是复发的独立预测因素(危险比[HR] 2.51,95%置信区间[CI] 1.09-5.79,p=0.031 和 HR 3.71,95% CI 1.58-8.73,p=0.003),但与总体死亡或 RCC 特异性死亡无关。

结论

CT 上不规则肿瘤轮廓特征与肿瘤异质性纹理特征的结合与临床 T1b-T2 RCC 术前 RFS 较差相关。

相似文献

1
Computer tomography-based shape of tumor contour and texture of tumor heterogeneity are independent prognostic indicators for clinical T1b-T2 renal cell carcinoma.计算机断层扫描(CT)成像下肿瘤轮廓的形状和肿瘤异质性的纹理是 T1b-T2 期肾细胞癌独立的预后指标。
World J Urol. 2023 Oct;41(10):2723-2734. doi: 10.1007/s00345-023-04543-4. Epub 2023 Aug 2.
2
Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.肿瘤大小对 T3a 期肾癌根治性肾切除术后患者生存的影响。
Jpn J Clin Oncol. 2019 May 1;49(5):465-472. doi: 10.1093/jjco/hyy200.
3
Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.部分肾切除术与根治性肾切除术相比,在老年 Ib-II 期肾肿块患者中并不具有总体生存优势:国家癌症数据库分析。
Cancer. 2018 Oct 1;124(19):3839-3848. doi: 10.1002/cncr.31582. Epub 2018 Sep 12.
4
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.嫌色细胞肾细胞癌(RCC):大型多中心系列中的肿瘤学结果和预后因素。
BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.
5
Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.在实施部分肾切除术的时代,肾细胞癌的组织学亚型对生存率有显著影响。
Urol Oncol. 2016 Jun;34(6):259.e1-8. doi: 10.1016/j.urolonc.2016.01.005. Epub 2016 Mar 2.
6
Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.T1N0M0期肾细胞癌:亚洲患者的预后
Chin J Cancer. 2011 Nov;30(11):772-8. doi: 10.5732/cjc.011.10085.
7
Comparison of survival and renal function between partial and radical laparoscopic nephrectomy for T1b renal cell carcinoma.部分腹腔镜与根治性腹腔镜肾切除术治疗 T1b 期肾癌的生存及肾功能比较。
J Cancer Res Clin Oncol. 2020 Jan;146(1):261-272. doi: 10.1007/s00432-019-03058-z. Epub 2019 Nov 1.
8
Preoperative serum low-density lipoprotein cholesterol is an independent prognostic factor in patients with renal cell carcinoma after nephrectomy.术前血清低密度脂蛋白胆固醇是肾细胞癌患者肾切除术后的独立预后因素。
Lipids Health Dis. 2023 Feb 22;22(1):26. doi: 10.1186/s12944-023-01791-6.
9
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.原发肿瘤小与转移性肾细胞癌预后的关系:接受细胞减灭性肾切除术的患者的两个独立队列的研究结果。
Eur Urol Oncol. 2020 Feb;3(1):47-56. doi: 10.1016/j.euo.2019.10.002. Epub 2019 Nov 14.
10
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?低危肾细胞癌患者行肾部分切除术与根治性肾切除术的术后随访是否应有所不同?
BJU Int. 2021 Sep;128(3):386-394. doi: 10.1111/bju.15415. Epub 2021 Apr 26.

引用本文的文献

1
Development and validation of a CT algorithm based on intratumoral necrosis and tumor morphology to predict the nuclear grade of small (2-4 cm) solid clear cell renal cell carcinoma.基于瘤内坏死和肿瘤形态学的CT算法的开发与验证,用于预测小(2 - 4厘米)实性透明细胞肾细胞癌的核分级
BMC Med Imaging. 2025 Jun 5;25(1):207. doi: 10.1186/s12880-025-01741-x.

本文引用的文献

1
Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study.肾肿瘤轮廓不规则评分对临床 T1 期肾癌病理 T3a 分期上调的预测价值:多中心研究。
Urol Oncol. 2022 May;40(5):199.e1-199.e8. doi: 10.1016/j.urolonc.2022.02.005. Epub 2022 Mar 29.
2
Tumor contour irregularity on preoperative imaging: a practical and useful prognostic parameter for papillary renal cell carcinoma.术前影像学上肿瘤轮廓不规则:预测肾乳头状细胞癌预后的一个实用且有用的参数。
Eur Radiol. 2021 Jun;31(6):3745-3753. doi: 10.1007/s00330-020-07456-7. Epub 2020 Nov 19.
3
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
组织学亚型对肾细胞癌患者手术后复发的发生率、时间和模式的影响——来自 RECUR 联盟的结果。
Eur Urol Oncol. 2021 Jun;4(3):473-482. doi: 10.1016/j.euo.2020.09.005. Epub 2020 Oct 24.
4
The Classification of Renal Cancer in 3-Phase CT Images Using a Deep Learning Method.基于深度学习方法的三期 CT 图像肾癌分类。
J Digit Imaging. 2019 Aug;32(4):638-643. doi: 10.1007/s10278-019-00230-2.
5
Grading of renal cell carcinoma.肾细胞癌分级。
Histopathology. 2019 Jan;74(1):4-17. doi: 10.1111/his.13735.
6
Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.根治性肾切除术与部分肾切除术治疗 cT1 期肾癌。
Eur Urol. 2018 Dec;74(6):825-832. doi: 10.1016/j.eururo.2018.08.028. Epub 2018 Sep 24.
7
Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.采用增强 CT 对以实体成分为主的乏脂性肾细胞癌进行鉴别诊断:评估纹理在肿瘤分型中的作用。
AJR Am J Roentgenol. 2018 Dec;211(6):W288-W296. doi: 10.2214/AJR.18.19551. Epub 2018 Sep 21.
8
Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma.预测透明细胞肾细胞癌患者长期总生存和疾病特异性生存的列线图。
Onco Targets Ther. 2018 Sep 6;11:5535-5544. doi: 10.2147/OTT.S171881. eCollection 2018.
9
Tumor necrosis as a prognostic variable for the clinical outcome in patients with renal cell carcinoma: a systematic review and meta-analysis.肿瘤坏死作为肾细胞癌患者临床结局的预后变量:系统评价和荟萃分析。
BMC Cancer. 2018 Sep 3;18(1):870. doi: 10.1186/s12885-018-4773-z.
10
Epidemiology and screening for renal cancer.肾癌的流行病学和筛查。
World J Urol. 2018 Sep;36(9):1341-1353. doi: 10.1007/s00345-018-2286-7. Epub 2018 Apr 2.